Stem Cell in Drug Discovery
Stem Cell in Drug Discovery:
As explained Stem Cells area unit general cells that have the aptitude to totally differentiate in to different sort of cells and tissues that area unit the building blocks of body, that's completed by the tactic of regeneration and degeneration which can accustomed overcome the constraints of animal models in bound disorders. Similarly as in drug screening and drug discovery. Several methods area unit accustomed generate such sickness models exploitation either embryonic stem cells (ES cells) or patient-specific induced PSCs (iPSCs), that's making new era within the sector of sickness modelling and drug discovery.
• High thought place screening exploitation iPSCs
• Drug screening
• Upset modelling
• Sickness modelling exploitation iPS cells
• Vegetative cell toxicity testing
Related Conference of Stem Cell in Drug Discovery
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cell in Drug Discovery Conference Speakers
Recommended Sessions
- 3D Bio-Printing and Organ Printing
- Advances in Stem Cells and their Niches
- Bio Banking
- Biomaterials and Biomedical Applications
- Bone Marrow Transplantation
- Cancer Stem Cell and Oncology
- Cell and Gene Therapy
- Cell Biology
- Cell Therapy for Cardiovascular and Neurological Disorders
- COVID-19 and Convalescent Plasma
- Dental Stem Cell
- Effect of Aging on Stem Cells
- Novel Stem Cell Techniques
- Regenerative Medicine research and development
- Regenerative Therapy in Osteoarthritis
- Stem Cell in Drug Discovery
- Stem Cells
- Stem Cells and Disease Modelling
- Stem Cells and Veterinary Applications
- Tissue Engineering
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
